EUVIMEDEUVIMED entdecken
Crossref

Design, Synthesis, Anticancer Evaluation and In Silico Studies of Imidazole Pyrazine Compounds

Gong Chen, Weiwei Li, Yuanhui Liu, Tong Li, Wenrun Zhu, Ying Liu, Xiaobao Jin, Qinghua Mei, Lianbao Ye iD

Chemistry & Biodiversity · 2025

DOI: 10.1002/cbdv.202401553 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Gong Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, 510006, People's Republic of China. Hauptthemen laut MEDLINE: Pyrazines, Imidazoles, Antineoplastic Agents, Drug Design. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Guangdong Pharmaceutical University-Special Projects in Key Fields of General Colleges and Universities in Guangdong Province, 2024 Guangdong Pharmaceutical University's "Discipline Training Excellence, Innovation and Quality Improvement" Engineering Team Project, Medical Scientific Research Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The present study focused on design and synthesis novel imidazolopyrazine derivatives, investigate the effect of them on the proliferation and migration of several human cancer cell lines by CCK‐8 method, and interactions with the JAKs by reverse molecular docking. It was found that most of the synthesized imidazolopyrazin derivatives exhibited excellent inhibitory effects towards three tested tutor cells in vitro . Among them, three compounds have IC 50 values much lower than Fluorouracil while show low toxicity to normal cells L‐02. The migration ability assay have proved that A6 and A9 effectively inhibit the migration of tumor cells. Reverse molecular docking studies indicated that the potent targets of these derivatives are JAKs as they well docked into kinases with low energy. These finding suggest that imidazo[1,5‐a]pyrazin derivatives may be lead compounds for developing potent JAK targeted anticancer candidates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyrazinesImidazolesAntineoplastic AgentsDrug DesignCell ProliferationMolecular Docking SimulationDrug Screening Assays, AntitumorHumansStructure-Activity RelationshipMolecular StructureCell Line, TumorCell MovementDose-Response Relationship, DrugProtein Kinase Inhibitors

Stichwörter der Autor:innen

Antitumor agentsImidazopyrazineJAKReverse molecular dockingSynthesis design

Substanzen

PyrazinesImidazolesAntineoplastic AgentsProtein Kinase Inhibitors

Autor:innen und Institutionen

  • School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, 510006, People's Republic of China.
  • Department of Laboratory Medicine, Guiyang Maternity and Child Health Hospital, Guiyang, 550003, People's Republic of China.
  • Guangdong Key Laboratory of Pharmaceutical Bioactive Substances, Guangdong Pharmaceutical University, Guangzhou, 510006, People's Republic of China.
  • Guangdong Second Provincial General Hospital, Guangzhou, 510317, People's Republic of China.

ORCID-Profile: Lianbao Ye

Förderung

  • Guangdong Pharmaceutical University-Special Projects in Key Fields of General Colleges and Universities in Guangdong Province
  • 2024 Guangdong Pharmaceutical University's "Discipline Training Excellence, Innovation and Quality Improvement" Engineering Team Project
  • Medical Scientific Research Foundation of Guangdong Province
  • Scientific Research Project of Guangdong Provincial Bureau of traditional Chinese Medicine
  • Guangzhou Basic and Applied Basic Research Special Project

Zitieren

APA

Chen, G., Li, W., Liu, Y., Li, T., Zhu, W., Liu, Y., Jin, X., Mei, Q., & Ye, L. (2025). Design, Synthesis, Anticancer Evaluation and In Silico Studies of Imidazole Pyrazine Compounds. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202401553

Vancouver

Chen G, Li W, Liu Y, Li T, Zhu W, Liu Y, et al. Design, Synthesis, Anticancer Evaluation and In Silico Studies of Imidazole Pyrazine Compounds. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202401553

BibTeX
@article{Chen2025,
  author = {Chen, Gong and Li, Weiwei and Liu, Yuanhui and Li, Tong and Zhu, Wenrun and Liu, Ying and Jin, Xiaobao and Mei, Qinghua and Ye, Lianbao},
  title = {Design, Synthesis, Anticancer Evaluation and In Silico Studies of Imidazole Pyrazine Compounds},
  journal = {Chemistry & Biodiversity},
  year = {2025},
  doi = {10.1002/cbdv.202401553}
}
Kostenlos starten →